Home » Archive

News

News, Syndication »

The Last Decade in Research: “Startling New Avenues of Discovery”

Posted by sandiegobiotech January 9th, 2014 .
No Comments

From her unique perspective as Vice Chancellor for Research – overseeing more than 20 organized research units among other duties – as well as a faculty member with decades of research experience, Sandra Brown says that the most striking change she has noticed in the university’s research enterprise over the last 10 years is the rise of new research combinations, the “strengths across disciplines” touted by the Chancellor.

More...

News, Syndication »

With New Funding, Avelas Moves Closer to Color-Coded Cancer Map

Posted by sandiegobiotech January 9th, 2014 .
No Comments

San Diego’s Avelas Biosciences says today it has closed on $6.85 million in Series B financing to advance the use of fluorescing peptides that can be used during breast cancer surgery to illuminate…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

U.S. Biomedical Research at a Precipice

Posted by sandiegobiotech January 9th, 2014 .
No Comments

[Editor's Note: this post was co-authored by Justin Chakma, Dr. Reshma Jagsi, and Stephen M. Sammut.] Since 1950, U.S. government funding has supported research underlying 84 percent of Nobel Prizes…

[[Click headline to continue reading.]]

More...

News, Syndication »

Regenerating myelin for multiple sclerosis requires “contactin-1”

Posted by sandiegobiotech January 7th, 2014 .
No Comments

Contactin-1 is required for myelination of neurons damaged by multiple sclerosis

More...

News, Syndication, UCSD News »

UC San Diego Names Steve Gamer Vice Chancellor – Advancement

Posted by sandiegobiotech January 6th, 2014 .
No Comments

The University of California, San Diego today announced the appointment of Steve Gamer as vice chancellor – advancement with responsibility for leading campus fundraising efforts and alumni relations; he will also serve as…

More...

News, Syndication »

Thermo Fisher Selling Units to Pave Way for Approval of Life Technologies Acquisition

Posted by sandiegobiotech January 6th, 2014 .
No Comments

Thermo Fisher Scientific Inc. is shedding certain assets to hasten approval of its $13.6 billion acquisition of Life Technologies Corp., selling its gene modulation, cell culture and magnetic beads businesses to GE Healthcare for $1.06 billion, Thermo …

More...

News, Syndication »

Bad Statistics, and Bad Training, Are Sabotaging Drug Discovery

Posted by sandiegobiotech January 6th, 2014 .
No Comments

One of the most widely read college textbooks in the 1960s and ‘70s was How to Lie with Statistics by Darrell Huff. Despite the humorous title, the serious intent of the book (written by a…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Josh Boger Finds Beauty Off the Coast of Fiji, in Life After Vertex

Posted by sandiegobiotech January 6th, 2014 .
No Comments

What has Josh Boger been doing the past four years in his supposed “retirement” from Vertex Pharmaceuticals? Turns out, he’s found peace and beauty. He discovered it about as far away from the…

[[Click headline to continue reading.]]

More...

News, Syndication »

Pharmaceutical Giants Expected to Have a Bigger Local Presence

Posted by sandiegobiotech January 4th, 2014 .
No Comments

The San Diego biotech sector is beginning to see a lot of activity among big pharma that has previously sidestepped the region — a trend that will continue to grow in 2014, said Joe Panetta, CEO of San Diego life sciences industry trade group Biocom.

More...

News, Syndication, UCSD News »

Statement from UC San Diego Chancellor Pradeep K. Khosla on the Death of Alumnus James Avery

Posted by sandiegobiotech January 3rd, 2014 .
No Comments

The passing of acclaimed actor, poet and alumnus James Avery is a great loss for UC San Diego. He was a strong champion of our campus, returning often to his alma mater as a featured guest and commencement speaker.

More...